Patents-Review.com
🔗 Permalink
Assignee profile:

SAMJIN PHARMACEUTICAL CO., LTD.

City:

Seoul

Country:

South Korea

Published Applications:

14

Last publication date:

2025-10-02

Patent Grants:

7

Last grant date:

2026-03-31

Top Inventors for applications by SAMJIN PHARMACEUTICAL CO., LTD.

These are the the leading inventors for applications assigned to SAMJIN PHARMACEUTICAL CO., LTD.:

Recent patent applications by SAMJIN PHARMACEUTICAL CO., LTD.

SAMJIN PHARMACEUTICAL CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-10-02
US20250304612A1
Chemistry; metallurgy

THERAPEUTIC AGENT FOR BLOOD CANCER

 #2 | 2025-09-11
US20250281472A1
Human necessities

OPHTHALMIC COMPOSITION INHIBITING OCCURRENCE OF N-OXOPYRIDINE COMPOUND FOR PREVENTING OR TREATING EYE DISEASE

 #3 | 2025-05-29
US20250171451A1
Chemistry; metallurgy

NOVEL HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

 #4 | 2023-06-22
US20230192752A1
Chemistry; metallurgy

THERAPEUTIC AGENT FOR BLOOD CANCER

 #5 | 2023-02-16 ✅ Patent 12,590,070 granted on 2026-03-31
US20230049557A1
Chemistry; metallurgy

NOVEL ADAMANTANE DERIVATIVES AS INHIBITORS OF FOCAL ADHESION KINASE

 #6 | 2023-01-26
US20230025836A1
Human necessities

EYE DROP COMPOSITION FOR PREVENTING OR TREATING EYE DISEASE

 #7 | 2022-07-14
US20220218685A1
Human necessities

COMPOSITION FOR TREATING EYE DISEASES

 #8 | 2019-10-03 ✅ Patent 10,844,062 granted on 2020-11-24
US20190300531A1
Chemistry; metallurgy

Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereof

 #9 | 2019-01-31 ✅ Patent 10,301,291 granted on 2019-05-28
US20190031645A1
Chemistry; metallurgy

Imidazole derivative having JNK inhibitory activity and use thereof

 #10 | 2018-09-20 ✅ Patent 10,918,725 granted on 2021-02-16
US20180264120A1
Human necessities

Ophthalmic composition comprising rebamipide and method for preparing the same

 #11 | 2016-03-24 ✅ Patent 11,712,414 granted on 2023-08-01
US20160081922A1
Human necessities

Oral pharmaceutical composition for preventing or treating dry eye syndrome comprising rebamipide or a prodrug thereof

 #12 | 2015-05-21 ✅ Patent 11,420,963 granted on 2022-08-23
US20150141409A1
Chemistry; metallurgy

Rebamipide prodrugs, preparation method and use thereof

 #13 | 2014-06-05
US20140154330A1
Human necessities

SPHERICAL PARTICLES OF CLOPIDOGREL BISULFATE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND PREPARATION METHOD THEREOF

 #14 | 2006-01-17 ✅ Patent 6,987,114 granted on 2006-01-17
US9719282
-

Antiviral pyrimidinedione derivatives and process for the preparation thereof

Also check out SAMJIN PHARMACEUTICAL CO., LTD.'s (Seoul, South Korea) applicant profile with 9 patent applications submitted.

AssigneeID:

66993 ⎘